Chinese expert consensus on the safety management of BTK inhibitors

Title: Chinese expert consensus on the safety management of BTK inhibitors
Edition: Original
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users:
Evidence classification method: GRADE
Development unit: Committee of Evidence-based Pharmacy, Chinese Pharmaceutical Society
Registration time: 2023-01-12
Registration number: PREPARE-2023CN029
Purpose of the guideline: